Highest On Record - Cronos Group Reports 46% YoY Increase In Q2 Net Revenue

Zinger Key Points
  • Cronos reported $27.8 million in net revenue during the second quarter, representing a 46% year-over-year increase.
  • Mike Gorenstein, chairman, president and CEO of Cronos, said this is the 'highest quarterly net revenue on record.'

Cronos Group Inc. CRON CRON announced on Tuesday its 2024 second-quarter business results.

The company reported $27.8 million in net revenue during the quarter, representing a 46% year-over-year increase.

Mike Gorenstein, chairman, president and CEO of Cronos, said that's the "highest quarterly net revenue on record."

"The top line was propelled by 46% growth year-over-year in Canada, 27% growth year-over-year in Israel, growth in Germany and the initiation of sales in the United Kingdom," Gorenstein continued. "These results reflect the hard work and dedication of our entire team, reinforcing our confidence in sustained growth and success."

In the second quarter of 2023, the company exited its U.S. hemp-derived CBD operations, representing a strategic shift.

Read Also: Cronos’ New Cannabis Products To Help You Breeze Through Summer

Q2 2024 Financial Highlights

  • Gross profit totaled $6.3 million, compared to $3.1 million in the same quarter of 2023.
  • Operating loss amounted to $15.6 million, down from $20.6 million in the same quarter of last fiscal year.
  • Net loss totaled $8.7 million, up from $8.5 million in the prior year's period.
  • Adjusted EBITDA, a non-GAAP measure, came in negative at $11 million, representing a year-over-year improvement from an adjusted EBITDA loss of $15.9 million in the prior year's quarter.

Meanwhile, Cronos announced an expansion of Cronos Growing Company Inc. in June. The investment will be funded by an additional credit facility provided by Cronos and is intended to assist GrowCo's expansion of its purpose-built cannabis facility to address the increased global market demand for high-quality cannabis flower.

Read Next

CRON Price Action

Cronos' shares traded 3.6% higher at $2.3 per share during the pre-market session on Thursday morning.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsCannabis EarningsCCCfinancial resultsMike Gorensteinsecond quarter earnings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.